GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Liabilities-to-Assets

Jubilant Pharmova (BOM:530019) Liabilities-to-Assets : 0.00 (As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Jubilant Pharmova's Total Liabilities for the quarter that ended in Jun. 2024 was ₹0 Mil. Jubilant Pharmova's Total Assets for the quarter that ended in Jun. 2024 was ₹0 Mil.


Jubilant Pharmova Liabilities-to-Assets Historical Data

The historical data trend for Jubilant Pharmova's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Liabilities-to-Assets Chart

Jubilant Pharmova Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.47 0.47 0.52 0.53

Jubilant Pharmova Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.53 - 0.53 -

Competitive Comparison of Jubilant Pharmova's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Pharmova's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Jubilant Pharmova's Liabilities-to-Assets falls into.



Jubilant Pharmova Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Jubilant Pharmova's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Liabilities-to-Assets (A: Mar. 2024 )=Total Liabilities/Total Assets
=61274/115485
=0.53

Jubilant Pharmova's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2024 is calculated as

Liabilities-to-Assets (Q: Jun. 2024 )=Total Liabilities/Total Assets
=0/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jubilant Pharmova  (BOM:530019) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Jubilant Pharmova Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Jubilant Pharmova Business Description

Traded in Other Exchanges
Address
1A, Sector 16A, Noida, UP, IND, 201 301
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova Headlines

No Headlines